Otsuka Holdings Co., Ltd. (OTSKY)
OTCMKTS
· Delayed Price · Currency is USD
25.96
-0.66 (-2.48%)
Mar 31, 2025, 11:55 AM EST
Otsuka Holdings Revenue
In the year 2024, Otsuka Holdings had annual revenue of 2.33T JPY with 15.42% growth. Otsuka Holdings had revenue of 599.79B in the quarter ending December 31, 2024, with 11.18% growth.
Revenue
2,329.86B JPY
Revenue Growth
+15.42%
P/S Ratio
n/a
Revenue / Employee
65.93M JPY
Employees
35,338
Market Cap
27.81B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
| Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
| Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
| Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
| Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 16.04M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| American Oncology Network | 1.76B |
Otsuka Holdings News
- 6 weeks ago - Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript - GuruFocus
- 6 weeks ago - Otsuka Holdings reports FY results - Seeking Alpha
- 5 months ago - Otsuka Holdings Co., Ltd. reports Q3 results - Seeking Alpha
- 5 months ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg